mRNA |
AZD0530 |
CCLE |
pan-cancer |
AAC |
-0.12 |
0.01 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.12 |
0.01 |
mRNA |
CP466722 |
GDSC1000 |
pan-cancer |
AAC |
-0.078 |
0.01 |
mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.01 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.02 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.02 |